While watching the news this morning about a break
Post# of 148288
I did some research on other break throughs for Alzheimer’s and Parkinson’s and found a new blood test break through in the UK that could allow more drugs to be trialed for these diseases. The blood test will allow trials to be much cheaper to use than standard testing used now where it would cost 300-400 million dollars to perform a trial.
This is good news for Leronlimab and should allow us a cheaper method to trial for these two diseases. When we are able to trial for these diseases. As we currently know, only 3% of all drugs cross the blood brain barrier in the brain and Leronlimab being one of them it could show great potential to help or cure these diseases. It’s on Ohms list and has been talked about in future trials.
https://www.fiercebiotech.com/medtech/blood-t...s-research